Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to demonstrate that AZD0837 is non-inferior to warfarin, aiming for an INR 2.0 to 3.0, target 2.5, in the prevention of the composite outcome variable of stroke and SEE.
Critère d'inclusion
- the prevention of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation (AF)